The RePo-SUDOE project has begun leading an innovative research group focused on drug repositioning, a key strategy for identifying new therapeutic applications for existing market-approved medications. This approach leverages advanced tools such as molecular modeling, computational simulations, and artificial intelligence (AI) algorithms to discover new indications for existing drugs, helping to accelerate the development of treatments for various diseases.
This project brings together prestigious institutions such as the Instituto Politécnico da Guarda (Portugal), the Universidade da Coruña, and the Universidade de Santiago de Compostela (Spain). Researchers are leveraging cutting-edge technologies, including molecular dynamics simulations and molecular docking, to better understand how drugs interact at the molecular level with proteins and cells—an approach that could revolutionize the way treatments are developed.
The research group is also involved in major European initiatives such as REPO4EU and REMEDi4ALL, which promote drug repositioning as a faster and more cost-effective alternative to the high costs and long development timelines of new pharmaceuticals.
With the support of digital tools and the power of advanced computing, RePo-SUDOE aims to accelerate the discovery of new treatments for diseases that currently lack effective therapeutic options. This international collaboration represents a significant breakthrough in the field of biomedicine, opening new opportunities for personalized medicine and the treatment of complex diseases.
